Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

By Dr Daniel R. Karlin, MD, MA Chief Medical Officer, MindMed

Articles by By Dr Daniel R. Karlin, MD, MA Chief Medical Officer, MindMed

Back to the Future: Psychedelics and a Return to the Concept of Recovery in Psychiatry

ByBy Dr Daniel R. Karlin, MD, MA Chief Medical Officer, MindMed

September 26th 2022

Latest Updated Articles

Back to the Future: Psychedelics and a Return to the Concept of Recovery in Psychiatry
September 26th 2022

Trending on Psychiatric Times

Interventional Options for TRD: ECT, TMS, and Esketamine

Defining Treatment-Resistant Depression In Adults